Registration Dates EXTENDED for Important Public Meeting
On behalf of the Food and Drug Administration (FDA), we invite you to an upcoming public meeting on alopecia areata to be held September 11, 2017, 1 PM to 5 PM (EDT) at the Food and Drug Administration Campus in Silver Spring, Maryland. The purpose of the meeting is to gather patients’ perspectives on health effects and daily impacts that matter most to them and to discuss views on treatment approaches for managing alopecia areata.
This meeting is an exciting opportunity for patients to bring their voice to the FDA and the drug development process. The meeting format maximizes patient participation. For each discussion topic, a small panel of patients or caregivers will briefly present comments to start the dialogue. The panel comments will be followed by a facilitated discussion with other patients and caregivers in the audience.
If you’re interested in serving as a panelist, please:
- Register here to attend the meeting in-person and indicate that you wish to serve on one of the two panels; and
- Submit a brief summary of your responses to the day’s discussion questions to PatientFocused@fda.hhs.gov by Monday, August 21.
Panelists will be confirmed prior to the meeting, and registration for the meeting will be open until Monday, August 28. If you are unable to attend the meeting in person, you can register to participate virtually by Sunday, September 10.